Eissa et al. reported that ELISA-based quantitative measurements of urinary angiogenic factor levels in voided urine samples were reliable [103], and all the studies included herein that assessed urinary ANG levels in bladder carcinoma reported that ANG levels were significantly elevated in patients with cancer compared with those in healthy controls. The gene discussed is ANG; the disease is urinary bladder carcinoma.